Home >> Biotechnology >> Consumer Goods >>

Global Cell and Gene Therapy Consumables Market Segments and By Region Global Industry Analysis on Growth Size Share Trends and Forecast (2019-2025)

Published: Jan-2020 | Format: PDF | Facts & Factors | Code: MRS - 708667

With the use of trusted market research methodologies our research analysts have concluded that the Cell and Gene Therapy Consumablesmarket size in terms of value is USD Million/Billion by 2025. The unparalleled level of in-depth study showcases the market dynamics. The Cell and Gene Therapy Consumables market report also deals with the latest breakthroughs taking place in the respective business domains. 
Our trusted proprietary tools and analyst views help in categorizing the trends that will stay in the long run or will be seen in the forecast period. The Cell and Gene Therapy Consumables market report focuses extensively on analyses of the key business models, major business strategies, and respective market share of few of the most prominent players in the competitive landscape. 
The report includes Porter’s Five Forces to analyze the competitive market forces and SWOT analysis to identify the strengths, weaknesses, opportunities, and threats of the market and/or of the organizations to evaluate its core potential. PESTEL analysis is incorporated for analyzing & monitoring macro-environmental factors impacting firm’s performance. These three tools account for macro & micro factors which directly or indirectly affect the Cell and Gene Therapy Consumables market at present as well as during the forecast period.
The study also featuremajorstrategic developments taking place in the Cell and Gene Therapy Consumablesmarket including research & development, acquisitions & mergers, agreements, partnerships, new service launches, and collaborations & joint ventures. The report provides an insight into the competitive moves adopted by the major market players to gain competitive advantage.
The market evolution during the 2019 to 2025 is due to the high rate of incidences of chronic disorders including cancer and heart ailments. Additionally, a surge in the occurrence of these ailments produces lucrative demand for new therapies and this will lead to huge market demand during the timespan from 2019-2025. Additionally, a large-scale awareness of the gene & cell treatments will soar the market growth during the period from 2019 to 2025. 
Comprehensive information of the key players in the Cell and Gene Therapy Consumables market is discussed in detail in the report. 
The report also includes:
• Analysis of the global market trends during the forecast period from 2019 to 2025 with 2018 being the base year 
• Historical data of the market is provided of years 2015, 2016, and 2017
• The report provides the dominating segments in the Cell and Gene Therapy Consumables market 
• The report has profiled details of the key industry players in the Cell and Gene Therapy Consumables market such as Amgen Inc., ATLANTA BIOLOGICALS, bluebird bio, Inc., Cook, Dendreon Pharmaceuticals, LLC, Fibrocell Science, Inc., General Electric, Kolon TissueGene, Inc., Orchard Therapeutics plc., Pfizer, Inc., PromoCell GmbH, RENOVA THERAPEUTICS, Sibiono GeneTech Co. Ltd., Spark Therapeutics, Inc., Vericel, Helixmith Co., Ltd., and Vitrolife.

This report segments the Cell and Gene Therapy Consumablesmarket as follows:
Cell and Gene Therapy ConsumablesMarket: By Product Type Segment Analysis
• Kits & Buffers
• Diagnostic Assay
• Culture Medium
o Natural Media
 Plasma
 Serum
 Lymph
 Human Placental Cord Serum
 Amniotic Fluid
 Others 
o Artificial Media
 MEM
 RPMI
 PBS
 DPBS
 HBSS
 EBSS
 Others
• Cryopreservation Media
Cell and Gene Therapy ConsumablesMarket: By Application/ Therapeutics Segment Analysis
• Cardiovascular
• Urology
• Dermatology
• Critical Care
• Respiratory
• Endocrine & Metabolic
• Neuroscience
• Hematology & Oncology
• Obstetrics
• Immunology
• Gastroenterology

Cell and Gene Therapy ConsumablesMarket: Regional Segment Analysis

• North America
o The U.S. 
o Canada
o Mexico
o Rest of North America
• Europe
o France
o The UK
o Spain
o Germany
o Italy
o Nordic Countries
 Denmark
 Finland
 Iceland
 Sweden
 Norway
o Benelux Union
 Belgium
 The Netherlands
 Luxembourg
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o New Zealand
o Australia
o South Korea
o Southeast Asia
 Indonesia
 Thailand
 Malaysia
 Singapore
 Rest of Southeast Asia
o Rest of Asia Pacific
• The Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa
• Latin America
o Brazil
o Argentina
o Rest of Latin America


Key Pointers Addressed by the Report
• Historical data and forecast analysis of the market
• Drivers and Restraints affecting market dynamics
• Exhaustive analysis about the future market trends 
• Comprehensive information about the leading market segments and region
• Strategic developments made by the competitive players and in-depth analysis about its impact on market growth
CHAPTER 1. Executive Summary 24
CHAPTER 2. Cell and Gene Therapy Consumables market – Product Type Analysis 27
2.1. Global Cell and Gene Therapy Consumables Market – Product Type Overview 27
2.2. Global Cell and Gene Therapy Consumables Market Share, by Product Type, 2018 & 2025 (USD Million) 27
2.3. Kits & Buffers 29
2.3.1. Global Kits & Buffers Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 29
2.4. Diagnostic Assay 30
2.4.1. Global Diagnostic Assay Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 30
2.5. Culture Medium 31
2.5.1. Global Culture Medium Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 31
2.6. Cryopreservation Media 32
2.6.1. Global Cryopreservation Media Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 32
CHAPTER 3. Cell and Gene Therapy Consumables market – Application Analysis 32
3.1. Global Cell and Gene Therapy Consumables Market – Application Overview 32
3.2. Global Cell and Gene Therapy Consumables Market Share, by Application, 2018 & 2025 (USD Million) 33
3.3. Cardiovascular 35
3.3.1. Global Cardiovascular Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 35
3.4. Urology 36
3.4.1. Global Urology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 36
3.5. Dermatology 37
3.5.1. Global Dermatology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 37
3.6. Critical Care 38
3.6.1. Global Critical Care Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 38
3.7. Respiratory 39
3.7.1. Global Respiratory Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 39
3.8. Endocrine & Metabolic 40
3.8.1. Global Endocrine & Metabolic Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 40
3.9. Neuroscience 41
3.9.1. Global Neuroscience Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 41
3.10. Hematology & Oncology 42
3.10.1. Global Hematology & Oncology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 42
3.11. Obstetrics 43
3.11.1. Global Obstetrics Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 43
3.12. Immunology 44
3.12.1. Global Immunology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 44
3.13. Gastroenterology 45
3.13.1. Global Gastroenterology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 45
CHAPTER 4. Cell and Gene Therapy Consumables market – Regional Analysis 46
4.1. Global Cell and Gene Therapy Consumables Market Regional Overview 46
4.2. Global Cell and Gene Therapy Consumables Market Share, by Region, 2018 & 2025 (Value) 46
4.3. North America 48
4.3.1. North America Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 48
4.3.2. North America Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 48
4.3.3. North America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 50
4.3.3.1. North America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 50
4.3.4. North America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 51
4.3.4.1. North America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 51
4.3.5. U.S. 52
4.3.5.1. U.S. Market size and forecast, 2015-2027 (USD Million) 52
4.3.6. Canada 53
4.3.6.1. Canada Market size and forecast, 2015-2027 (USD Million) 53
4.3.7. Mexico 54
4.3.7.1. Mexico Market size and forecast, 2015-2027 (USD Million) 54
4.4. Europe 55
4.4.1. Europe Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 55
4.4.2. Europe Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 55
4.4.3. Europe Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 57
4.4.3.1. Europe Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 57
4.4.4. Europe Cell and Gene Therapy Consumables Market, by Application, 2015-2027 58
4.4.4.1. Europe Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 58
4.4.5. Germany 59
4.4.5.1. Germany Market size and forecast, 2015-2027 (USD Million) 59
4.4.6. France 60
4.4.6.1. France Market size and forecast, 2015-2027 (USD Million) 60
4.4.7. U.K. 61
4.4.7.1. U.K. Market size and forecast, 2015-2027 (USD Million) 61
4.4.8. Italy 62
4.4.8.1. Italy Market size and forecast, 2015-2027 (USD Million) 62
4.4.9. Spain 63
4.4.9.1. Spain Market size and forecast, 2015-2027 (USD Million) 63
4.4.10. Nordic Countries 64
4.4.10.1. Nordic Countries Market size and forecast, 2015-2027 (USD Million) 64
4.4.11. Benelux Union 65
4.4.11.1. Benelux Union Market size and forecast, 2015-2027 (USD Million) 65
4.4.12. Rest of Europe 66
4.4.12.1. Rest of Europe Market size and forecast, 2015-2027 (USD Million) 66
4.5. Asia Pacific 67
4.5.1. Asia Pacific Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 67
4.5.2. Asia Pacific Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 67
4.5.3. Asia Pacific Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 69
4.5.3.1. Asia Pacific Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 69
4.5.4. Asia Pacific Cell and Gene Therapy Consumables Market, by Application, 2015-2027 70
4.5.4.1. Asia Pacific Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 70
4.5.5. China 71
4.5.5.1. China Market size and forecast, 2015-2027 (USD Million) 71
4.5.6. Japan 72
4.5.6.1. Japan Market size and forecast, 2015-2027 (USD Million) 72
4.5.7. India 73
4.5.7.1. India Market size and forecast, 2015-2027 (USD Million) 73
4.5.8. New Zealand 74
4.5.8.1. New Zealand Market size and forecast, 2015-2027 (USD Million) 74
4.5.9. Australia 75
4.5.9.1. Australia Market size and forecast, 2015-2027 (USD Million) 75
4.5.10. South  Korea 76
4.5.10.1. South  Korea Market size and forecast, 2015-2027 (USD Million) 76
4.5.11. South-East Asia 77
4.5.11.1. South-East Asia Market size and forecast, 2015-2027 (USD Million) 77
4.5.12. Rest of Asia Pacific 78
4.5.12.1. Rest of Asia Pacific Market size and forecast, 2015-2027 (USD Million) 78
4.6. Latin America 79
4.6.1. Latin America Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 79
4.6.2. Latin America Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 79
4.6.3. Latin America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 81
4.6.3.1. Latin America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 81
4.6.4. Latin America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 82
4.6.4.1. Latin America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 82
4.6.5. Brazil 83
4.6.5.1. Brazil Market size and forecast, 2015-2027 (USD Million) 83
4.6.6. Argentina 84
4.6.6.1. Argentina Market size and forecast, 2015-2027 (USD Million) 84
4.6.7. Rest of Latin America 85
4.6.7.1. Rest of Latin America Market size and forecast, 2015-2027 (USD Million) 85
4.7. The Middle-East and Africa 86
4.7.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 86
4.7.2. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 86
4.7.3. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 88
4.7.3.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 88
4.7.4. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Application, 2015-2027 89
4.7.4.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 89
4.7.5. Saudi Arabia 90
4.7.5.1. Saudi Arabia Market size and forecast, 2015-2027 (USD Million) 90
4.7.6. UAE 91
4.7.6.1. UAE Market size and forecast, 2015-2027 (USD Million) 91
4.7.7. Egypt 92
4.7.7.1. Egypt Market size and forecast, 2015-2027 (USD Million) 92
4.7.8. Kuwait 93
4.7.8.1. Kuwait Market size and forecast, 2015-2027 (USD Million) 93
4.7.9. South Africa 94
4.7.9.1. South Africa Market size and forecast, 2015-2027 (USD Million) 94
4.7.10. Rest of Middle-East Africa 95
4.7.10.1. Rest of Middle-East Africa Market size and forecast, 2015-2027 (USD Million) 95
CHAPTER 5. Cell and Gene Therapy Consumables market – Competitive Landscape 96
5.1. Competitor Market Share – Revenue 96
5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 98
5.3. Strategic Development 99
5.3.1. Acquisitions and Mergers 99
5.3.2. New Products 99
5.3.3. Research & Development Activities 99
CHAPTER 6. Company Profiles 100
6.1. Amgen Inc. 100
6.1.1. Company Overview 100
6.1.2. Amgen Inc. Revenue and Gross Margin 100
6.1.3. Product portfolio 101
6.1.4. Recent initiatives 102
6.2. ATLANTA BIOLOGICALS 102
6.2.1. Company Overview 102
6.2.2. ATLANTA BIOLOGICALS Revenue and Gross Margin 102
6.2.3. Product portfolio 103
6.2.4. Recent initiatives 104
6.3. bluebird bio Inc. 104
6.3.1. Company Overview 104
6.3.2. bluebird bio Inc. Revenue and Gross Margin 104
6.3.3. Product portfolio 105
6.3.4. Recent initiatives 106
6.4. Cook 106
6.4.1. Company Overview 106
6.4.2. Cook Revenue and Gross Margin 106
6.4.3. Product portfolio 107
6.4.4. Recent initiatives 108
6.5. Dendreon Pharmaceuticals LLC 108
6.5.1. Company Overview 108
6.5.2. Dendreon Pharmaceuticals LLC Revenue and Gross Margin 108
6.5.3. Product portfolio 109
6.5.4. Recent initiatives 110
6.6. Fibrocell Science Inc. 110
6.6.1. Company Overview 110
6.6.2. Fibrocell Science Inc. Revenue and Gross Margin 110
6.6.3. Product portfolio 111
6.6.4. Recent initiatives 112
6.7. General Electric 112
6.7.1. Company Overview 112
6.7.2. General Electric Revenue and Gross Margin 112
6.7.3. Product portfolio 113
6.7.4. Recent initiatives 114
6.8. Kolon TissueGene Inc. 114
6.8.1. Company Overview 114
6.8.2. Kolon TissueGene Inc. Revenue and Gross Margin 114
6.8.3. Product portfolio 115
6.8.4. Recent initiatives 116
6.9. Orchard Therapeutics plc. 116
6.9.1. Company Overview 116
6.9.2. Orchard Therapeutics plc. Revenue and Gross Margin 116
6.9.3. Product portfolio 117
6.9.4. Recent initiatives 118
6.10. Pfizer Inc. 118
6.10.1. Company Overview 118
6.10.2. Pfizer Inc. Revenue and Gross Margin 118
6.10.3. Product portfolio 119
6.10.4. Recent initiatives 120
6.11. PromoCell GmbH 120
6.11.1. Company Overview 120
6.11.2. PromoCell GmbH Revenue and Gross Margin 120
6.11.3. Product portfolio 121
6.11.4. Recent initiatives 122
6.12. RENOVA THERAPEUTICS 122
6.12.1. Company Overview 122
6.12.2. RENOVA THERAPEUTICS Revenue and Gross Margin 122
6.12.3. Product portfolio 123
6.12.4. Recent initiatives 124
6.13. Sibiono GeneTech Co. Ltd. 124
6.13.1. Company Overview 124
6.13.2. Sibiono GeneTech Co. Ltd. Revenue and Gross Margin 124
6.13.3. Product portfolio 125
6.13.4. Recent initiatives 126
6.14. Spark Therapeutics Inc. 126
6.14.1. Company Overview 126
6.14.2. Spark Therapeutics Inc. Revenue and Gross Margin 126
6.14.3. Product portfolio 127
6.14.4. Recent initiatives 128
6.15. Vericel 128
6.15.1. Company Overview 128
6.15.2. Vericel Revenue and Gross Margin 128
6.15.3. Product portfolio 129
6.15.4. Recent initiatives 130
6.16. Helixmith Co. Ltd. 130
6.16.1. Company Overview 130
6.16.2. Helixmith Co. Ltd. Revenue and Gross Margin 130
6.16.3. Product portfolio 131
6.16.4. Recent initiatives 132
6.17. Vitrolife 132
6.17.1. Company Overview 132
6.17.2. Vitrolife Revenue and Gross Margin 132
6.17.3. Product portfolio 133
6.17.4. Recent initiatives 134
CHAPTER 7. Cell and Gene Therapy Consumables — Industry Analysis 135
7.1. Cell and Gene Therapy Consumables Market – Key Trends 135
7.1.1. Market Drivers 136
7.1.2. Market Restraints 136
7.1.3. Market Opportunities 137
7.2. Value Chain Analysis 138
7.3. Technology Roadmap and Timeline 139
7.4. Cell and Gene Therapy Consumables Market – Attractiveness Analysis 140
7.4.1. By Product Type 140
7.4.2. By Application 140
7.4.3. By Region 142
CHAPTER 8. Marketing Strategy Analysis, Distributors 143
8.1. Marketing Channel 143
8.2. Direct Marketing 144
8.3. Indirect Marketing 144
8.4. Marketing Channel Development Trend 144
8.5. Economic/Political Environmental Change 145
CHAPTER 9. Report Conclusion 146
CHAPTER 10. Research Approach & Methodology 147
10.1. Report Description 147
10.2. Research Scope 148
10.3. Research Methodology 148
10.3.1. Secondary Research 149
10.3.2. Primary Research 150
10.3.3. Models 151
10.3.3.1. Company Share Analysis Model 151
10.3.3.2. Revenue Based Modeling 152
10.3.3.3. Research Limitations 152


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2900 View Pricing